Many Distinct Ways Lead to Drug Resistance in BRAF- and NRAS-Mutated Melanomas

Advanced melanoma is a relentless tumor with a high metastatic potential. The combat of melanoma by using the targeted therapy is impeded because several major driver mutations fuel its growth (predominantly BRAF and NRAS). Both these mutated oncogenes strongly activate the MAPK (MEK/ERK) pathway. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Vachtenheim, Jiri, Ondrušová, Lubica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148104/
https://www.ncbi.nlm.nih.gov/pubmed/34063141
http://dx.doi.org/10.3390/life11050424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148104/
https://www.ncbi.nlm.nih.gov/pubmed/34063141
http://dx.doi.org/10.3390/life11050424

Ejemplares similares